NANO MRNA Co.,Ltd. (TYO:4571)
Japan
· Delayed Price · Currency is JPY 133.00
-1.00 (-0.75%)
May 2, 2025, 3:30 PM JST
NANO MRNA Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2010 | FY 2009 | FY 2008 | 2006 - 2007 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 | 2006 - 2007 |
| Revenue | 114 | 135 | 202 | 117.82 | 353.65 | 262.72 | Upgrade
|
| Revenue Growth (YoY) | -30.49% | -33.17% | 71.45% | -66.68% | 34.61% | 154.01% | Upgrade
|
| Cost of Revenue | 35 | 24 | 43 | 70.93 | 247.31 | 68.32 | Upgrade
|
| Gross Profit | 79 | 111 | 159 | 46.89 | 106.34 | 194.4 | Upgrade
|
| Selling, General & Admin | 94 | 328 | 285 | 320.35 | 310.04 | 317.07 | Upgrade
|
| Research & Development | 647 | 647 | 1,120 | 219.23 | 295.59 | 329.86 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 32.51 | - | Upgrade
|
| Operating Expenses | 741 | 975 | 1,405 | 539.59 | 638.15 | 646.94 | Upgrade
|
| Operating Income | -662 | -864 | -1,246 | -492.7 | -531.81 | -452.54 | Upgrade
|
| Interest Expense | - | - | -5 | - | - | - | Upgrade
|
| Interest & Investment Income | 32 | 26 | 25 | 2.84 | 7.35 | 6.54 | Upgrade
|
| Currency Exchange Gain (Loss) | 52 | 54 | 60 | 0.44 | -0.07 | -2.39 | Upgrade
|
| Other Non Operating Income (Expenses) | 45 | 34 | 61 | -3.93 | 1.36 | -43.22 | Upgrade
|
| EBT Excluding Unusual Items | -533 | -750 | -1,105 | -493.34 | -523.18 | -491.61 | Upgrade
|
| Gain (Loss) on Sale of Investments | -104 | 42 | -268 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 1 | 4 | - | 1.66 | - | Upgrade
|
| Asset Writedown | -2 | -71 | -6 | -0.03 | -0.03 | -0 | Upgrade
|
| Other Unusual Items | - | - | 67 | 1 | -0.52 | - | Upgrade
|
| Pretax Income | -639 | -778 | -1,308 | -492.37 | -522.06 | -491.61 | Upgrade
|
| Income Tax Expense | -1 | 2 | 2 | 2.42 | 2.42 | 2.42 | Upgrade
|
| Net Income | -638 | -780 | -1,310 | -494.79 | -524.48 | -494.03 | Upgrade
|
| Net Income to Common | -638 | -780 | -1,310 | -494.79 | -524.48 | -494.03 | Upgrade
|
| Shares Outstanding (Basic) | 70 | 70 | 70 | 13 | 13 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 70 | 70 | 70 | 13 | 13 | 9 | Upgrade
|
| Shares Change (YoY) | 0.33% | 0.29% | 448.88% | 2.13% | 38.31% | 44.55% | Upgrade
|
| EPS (Basic) | -9.05 | -11.10 | -18.69 | -38.75 | -41.95 | -54.65 | Upgrade
|
| EPS (Diluted) | -9.05 | -11.10 | -18.69 | -38.75 | -41.95 | -54.65 | Upgrade
|
| Free Cash Flow | - | -585 | -1,087 | -454.43 | -459.59 | -602.38 | Upgrade
|
| Free Cash Flow Per Share | - | -8.32 | -15.51 | -35.59 | -36.76 | -66.63 | Upgrade
|
| Gross Margin | 69.30% | 82.22% | 78.71% | 39.80% | 30.07% | 74.00% | Upgrade
|
| Operating Margin | -580.70% | -640.00% | -616.83% | -418.18% | -150.38% | -172.25% | Upgrade
|
| Profit Margin | -559.65% | -577.78% | -648.51% | -419.95% | -148.31% | -188.05% | Upgrade
|
| Free Cash Flow Margin | - | -433.33% | -538.12% | -385.70% | -129.96% | -229.29% | Upgrade
|
| EBITDA | - | -863 | - | -479.59 | -516.05 | -437.71 | Upgrade
|
| EBITDA Margin | - | - | - | - | -145.92% | -166.61% | Upgrade
|
| D&A For EBITDA | - | 1 | - | 13.1 | 15.76 | 14.83 | Upgrade
|
| EBIT | -662 | -864 | -1,246 | -492.7 | -531.81 | -452.54 | Upgrade
|
| EBIT Margin | - | - | - | - | -150.38% | -172.25% | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.